Patient Voices Needed for CGRP Insurance Coverage

Patients with migraine disease are being asked to share their stories for considerartion during a review of a new CGRP (calcitonin-gene-related peptide) medication by the Institute of Clinical and Economic Review (ICER).

What is ICER?

The purpose of ICER is to assess the cost-effectiveness of medical therapies and medicines. At the conclusion of this migraine disease review, ICER will publish a report on the cost-effectiveness of CGRP, a new class of drugs that is currently being reviewed by the FDA for approval.

ICER’s report will be used by insurance companies when determining how they will cover CGRP medicines, which could ultimately affect a patient’s access to these medications.

How much will CGRP cost?

ICER will be conducting research for their report from researchers, health economists, biotech companies, doctors and patients. These are the types of questions that will be influenced by this ICER report:

  • Will insurance companies pay for CGRP under the plans they offer?
  • What price will insurance companies be willing to pay for CGRP medicines?
  • How much of the cost will patients be expected to cover for these new medicines?
  • Will insurance companies require patients to try and fail on other medications before being approved for CGRP medicines?

Patient voices needed by November 30

It is important that the patient voice is heard. The stigma surrounding migraine and its debilitating effects are often dismissed. This is a chance for you to discuss how migraine disease affects your life. Share your frustrations over the limited effectiveness and the side-effects of current migraine medications and express the patient need for new and better treatments for migraine disease.

If you would like to give your input to ICER, there is a very short time period in which to participate. The deadline is Thursday, November 30, 2017 at 5:00pm ET.

The online form for patients to answer questions and submit input to ICER can be accessed here.

For further guidance on the key points to convey to ICER, please visit the Headache and Migraine Policy Forum for tips on how to fill out the form: The Headache and Migraine Policy Forum has prepared this information and guidance here.

Comments

View Comments (7)

Poll